AFEDITAB Trademark

Trademark Overview

On Monday, September 30, 2002, a trademark application was filed for AFEDITAB with the United States Patent and Trademark Office. The USPTO has given the AFEDITAB trademark a serial number of 76455223. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 29, 2024. This trademark is owned by Watson Pharmaceuticals, Inc.. The AFEDITAB trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

General Information

Serial Number76455223
Word MarkAFEDITAB
Filing DateMonday, September 30, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 29, 2024
Registration Number2843689
Registration DateTuesday, May 18, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 1, 2003

Trademark Statements

Goods and ServicesPHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 29, 2024
Primary Code005
First Use Anywhere DateFriday, June 20, 2003
First Use In Commerce DateFriday, June 20, 2003

Trademark Owner History

Party NameACTAVIS HOLDCO US, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPARSIPPANY, NJ 07054
Party NameACTAVIS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPARSIPPANY, NJ 07054
Party NameWatson Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCorona, CA 928802882
Party NameWatson Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCorona, CA 928802882
Party NameWatson Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCorona, CA 928802882

Trademark Events

Event DateEvent Description
Monday, February 3, 2003ASSIGNED TO EXAMINER
Tuesday, February 4, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2003NOTICE OF PUBLICATION
Tuesday, April 1, 2003PUBLISHED FOR OPPOSITION
Tuesday, June 24, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 11, 2003PAPER RECEIVED
Monday, August 11, 2003USE AMENDMENT FILED
Monday, August 11, 2003STATEMENT OF USE PROCESSING COMPLETE
Sunday, September 28, 2003CASE FILE IN TICRS
Monday, September 29, 2003ASSIGNED TO EXAMINER
Friday, October 10, 2003NON-FINAL ACTION MAILED
Friday, February 20, 2004PAPER RECEIVED
Friday, February 20, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 16, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 18, 2004REGISTERED-PRINCIPAL REGISTER
Wednesday, January 3, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 12, 2009TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 16, 2009ASSIGNED TO PARALEGAL
Wednesday, July 15, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, August 28, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 16, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 1, 2014TEAS SECTION 8 & 9 RECEIVED
Thursday, May 1, 2014REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, May 14, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 14, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, May 14, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, May 14, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, February 22, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 18, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 29, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

afeditab diseases cardiovascular treatment pharmaceuticals